663
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Modulation of ionizing radiation-induced damage in human blood lymphocytes by in vivo treatment with resveratrol

ORCID Icon, &
Pages 1220-1225 | Received 30 Dec 2018, Accepted 25 Apr 2019, Published online: 21 Jun 2019

References

  • American Cancer Society. 2019. Radiation Therapy for Endometrial Cancer. [accessed 2019 Jun 3]. https://www.cancer.org/cancer/endometrial-cancer/treating/radiation.html
  • American Society of Clinical Oncology. 2017. Uterine Cancer: Treatment Options. [accessed 2019 Jun 3]. https://www.cancer.net/cancer-types/uterine-cancer/treatment-options
  • Arnold KM, Flynn NJ, Raben A, Romak L, Yu Y, Dicker AP, Mourtada F, Sims-Mourtada J. 2018. The impact of radiation on the tumor microenvironment: effect of dose and fractionation schedules. Cancer Growth Metastasis. 11:1–17.
  • Banegas YC, Ocolotobiche EE, Padula G, Córdoba EE, Fernández E, Güerci AM. 2018. Evaluation of resveratrol radiomodifying potential for radiotherapy treatment. Mutat Res Gen Tox En. 836:79–83.
  • Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG. 2015. Incorporating genetic biomarkers into predictive models of normal tissue toxicity. Clin Oncol (R Coll Radiol). 27:579–587.
  • Brisdelli F, D'Andrea G, Bozzi A. 2009. Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab. 10:530–546.
  • Carsten RE, Bachand AM, Bailey SM, Ullrich RL. 2008. Resveratrol reduces radiation-induced chromosome aberration frequencies in mouse bone marrow cells. Radiat Res. 169:633–638.
  • Carter LG, D'Orazio JA, Pearson KJ. 2014. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 21:R209–R225.
  • Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. 2010. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist. 15:360–371.
  • Collins AR, Ma AG, Duthie SJ. 1995. The kinetics of repair of oxidative DNA damage (strand breaks and oxidized pyrimidine) in human cells. Mutat Res. 336:69–77.
  • Delmas D, Lancon A, Colin D, Jannin B, Latruffe N. 2006. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets. 7:423–442.
  • Dobrzyńska MM, Gajowik A, Radzikowska J. 2016. The effect of in vivo resveratrol supplementation in irradiated mice on the induction of micronuclei in peripheral blood and bone marrow reticulocytes. Mutagenesis. 31:393–399.
  • Fabre KM, Saito K, DeGraff W, Sowers AL, Thetford A, Cook JA, Krishna MC, Mitchell JB. 2011. The effects of resveratrol and selected metabolites on the radiation and antioxidant response. Cancer Biol Ther. 12:915–923.
  • GLOBOCAN, IARC Global Cancer Observatory. 2018. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. PRESS RELEASE N° 263. https://www.iarc.fr/wp-content/uploads/2018/09/pr263_E.pdf
  • Güerci AM, Córdoba EE. 2015. Nuevo Enfoque de los efectos biológicos de las radiaciones. Revista Argentina de Radiobiología. 79:224–225.
  • Koohian F, Shanei A, Shahbazi-Gahrouei D, Hejazi SH, Moradi MT. 2017. The radioprotective effect of resveratrol against genotoxicity induced by gamma-irradiation in mice blood lymphocytes. Dose Response. 15:1559325817705699.
  • Kumaravel TS, Vilhar B, Faux SP, Jha AN. 2009. Comet Assay measurements: a perspective. Cell Biol Toxicol. 25:53–64.
  • Kundu JK, Surh YJ. 2008. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 269:243–261.
  • Li J, Feng L, Xing Y, Wang Y, Du L, Xu C, Cao J, Wang Q, Fan S, Liu Q, et al. 2014. Radioprotective and antioxidant effect of resveratrol in hippocampus by activating Sirt1. Int J Mol Sci. 15:5928–5939.
  • Meng J, Guo F, Xu H, Liang W, Wang C, Yang XD. 2016. Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci Rep. 6:22390.
  • Olive PL. 2009. Impact of the comet assay in radiobiology. Mutat Res. 681:13–23.
  • Poulsen MM, Fjeldborg K, Ornstrup MJ, Kjaer TN, Nøhr MK, Pedersen SB. 2015. Resveratrol and inflammation: challenges in translating pre-clinical findings to improved patient outcomes. Biochim Biophys Acta. 1852:1124–1136.
  • Raabe A, Derda K, Reuther S, Szymczak S, Borgmann K, Hoeller U, Ziegler A, Petersen C, Dikomey E. 2012. Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy. Radiat Oncol. 7:65.
  • Sebastia N, Almonacid M, Villaescusa JI, Cervera J, Such E, Silla MA, Soriano JM, Montoro A. 2013. Radioprotective activity and cytogenetic effect of resveratrol in human lymphocytes: an in vitro evaluation. Food Chem Toxicol. 51:391–395.
  • Sebastia N, Montoro A, Hervas D, Pantelias G, Hatzi VI, Soriano JM, Villaescusa JI, Terzoudi GI. 2014. Curcumin and trans-resveratrol exert cell cycle-dependent radioprotective or radiosensitizing effects as elucidated by the PCC and G2-assay. Mutat Res. 766–767:49–55.
  • Sergides C, Chirilă M, Silvestro L, Pitta D, Pittas A. 2016. Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Exp Ther Med. 11:164–170.
  • Shukla Y, Singh R. 2011. Resveratrol and cellular mechanisms of cancer prevention. Ann N Y Acad Sci. 1215:1–8.
  • Singh CK, Liu X, Ahmad N. 2015. Resveratrol, in its natural combination in whole grape, for health promotion and disease management. Ann N Y Acad Sci. 1348:150–160.
  • Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:184–191.
  • Soldati L, Di Renzo L, Jirillo E, Ascierto PA, Marincola FM, De Lorenzo A. 2018. The influence of diet on anti-cancer immune responsiveness. J Transl Med. 16:75.
  • Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJ. 2008. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev. 66:445–454.
  • United Nations Scientific Committee on the Effects of Atomic Radiation. 2008. Sources and effects of ionizing radiation. Report to the General Assembly with scientific annexes. 1 A.
  • van Meir H, Nout RA, Welters MJP, Loof NM, de Kam ML, van Ham JJ, Samuels S, Kenter GG, Cohen AF, Melief CJM, et al. 2017. Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients. Oncoimmunology. 6:e1267095.
  • Vijayananthan A, Nawawi O. 2008. The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imaging Interv J. 4:e5.
  • West CM, Barnett GC. 2011. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 3:52.
  • Yi L, Tian M, Piao C, Gao G, Wu L, Pan Y, Li J. 2019. The protective effects of 1,2-propanediol against radiation-inducedhematopoietic injury in mice. Biomed Pharmacother J. 114:108806.
  • Zhang H, Zhai Z, Wang Y, Zhang J, Wu H, Wang Y, Li C, Li D, Lu L, Wang X, et al. 2013. Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 54:40–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.